{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T07:56:47Z","timestamp":1720598207088},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,7,19]],"date-time":"2015-07-19T00:00:00Z","timestamp":1437264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s11864-015-0363-3","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T08:43:23Z","timestamp":1437209003000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Surgical Options in the Treatment of Lower Gastrointestinal Tract Cancers"],"prefix":"10.1007","volume":"16","author":[{"given":"Andrea S.","family":"Porpiglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elin R.","family":"Sigurdson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,19]]},"reference":[{"issue":"2","key":"363_CR1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3322\/caac.21220","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104\u201317.","journal-title":"CA Cancer J Clin"},{"key":"363_CR2","doi-asserted-by":"crossref","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108. doi: 10.3322\/caac.21262 .","DOI":"10.3322\/caac.21262"},{"issue":"6","key":"363_CR3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/COC.0b013e3181fe41ed","volume":"34","author":"L Cheng","year":"2011","unstructured":"Cheng L et al. Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol. 2011;34(6):573\u201380.","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"363_CR4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759\u201367.","journal-title":"Cell"},{"issue":"8","key":"363_CR5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/DCR.0b013e3182567e13","volume":"55","author":"GJ Chang","year":"2012","unstructured":"Chang GJ et al. Practice parameters for the management of colon cancer. Dis Colon Rectum. 2012;55(8):831\u201343.","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"363_CR6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.seminoncol.2007.03.005","volume":"34","author":"A Rajput","year":"2007","unstructured":"Rajput A, Bullard Dunn K. Surgical management of rectal cancer. Semin Oncol. 2007;34(3):241\u20139.","journal-title":"Semin Oncol"},{"key":"363_CR7","unstructured":"American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. New York: Springer-Verlag; 2010. p. 648"},{"issue":"1","key":"363_CR8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1470-2045(08)70310-3","volume":"10","author":"Colon Cancer Laparoscopic or Open Resection Study, G","year":"2009","unstructured":"Colon Cancer Laparoscopic or Open Resection Study, G et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical tria. Lancet Oncol. 2009;10(1):44\u201352.","journal-title":"Lancet Oncol"},{"issue":"21","key":"363_CR9","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2006.09.7758","volume":"25","author":"DG Jayne","year":"2007","unstructured":"Jayne DG et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol. 2007;25(21):3061\u20138.","journal-title":"J Clin Oncol"},{"issue":"7","key":"363_CR10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1470-2045(05)70221-7","volume":"6","author":"R Veldkamp","year":"2005","unstructured":"Veldkamp R et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol. 2005;6(7):477\u201384.","journal-title":"Lancet Oncol"},{"issue":"5","key":"363_CR11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/SLA.0b013e31818b7595","volume":"248","author":"PJ Hewett","year":"2008","unstructured":"Hewett PJ et al. Short-term outcomes of the Australasian randomized clinical study comparing laparoscopic and conventional open surgical treatments for colon cancer: the ALCCaS trial. Ann Surg. 2008;248(5):728\u201338.","journal-title":"Ann Surg"},{"key":"363_CR12","doi-asserted-by":"crossref","unstructured":"The Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004;350:2050\u20139. doi: 10.1056\/NEJMoa032651 .","DOI":"10.1056\/NEJMoa032651"},{"issue":"6","key":"363_CR13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3349\/ymj.2008.49.6.891","volume":"49","author":"SH Baik","year":"2008","unstructured":"Baik SH. Robotic colorectal surgery. Yonsei Med J. 2008;49(6):891\u20136.","journal-title":"Yonsei Med J"},{"key":"363_CR14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/1477-7819-12-274","volume":"12","author":"H Xu","year":"2014","unstructured":"Xu H et al. Robotic versus laparoscopic right colectomy: a meta-analysis. World J Surg Oncol. 2014;12:274. A meta-analysis evaluating robotic surgery in comparison to laparoscopic colorectal surgery. The study specifically evaluates short-term outcomes of the two minimally invasive surgical procedures.","journal-title":"World J Surg Oncol"},{"issue":"12","key":"363_CR15","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.6004\/jnccn.2012.0158","volume":"10","author":"AB Benson 3rd","year":"2012","unstructured":"Benson 3rd AB et al. Rectal cancer. J Natl Compr Cancer Netw. 2012;10(12):1528\u201364. NCCN guidelines for the treatment of rectal cancer.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"7","key":"363_CR16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.6004\/jnccn.2014.0099","volume":"12","author":"AB Benson 3rd","year":"2014","unstructured":"Benson 3rd AB et al. Colon cancer, version 3.2014. J Natl Compr Cancer Netw. 2014;12(7):1028\u201359. NCCN guidelines for the treatment of rectal cancer.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"66","key":"363_CR17","first-page":"1688","volume":"52","author":"WL Fang","year":"2005","unstructured":"Fang WL et al. Metastatic potential in T1 and T2 colorectal cancer. Hepatogastroenterology. 2005;52(66):1688\u201391.","journal-title":"Hepatogastroenterology"},{"issue":"6","key":"363_CR18","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s10350-004-0935-y","volume":"48","author":"HS Wang","year":"2005","unstructured":"Wang HS et al. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis Colon Rectum. 2005;48(6):1182\u201392.","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"363_CR19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/DCR.0000000000000168","volume":"57","author":"T Nishida","year":"2014","unstructured":"Nishida T et al. Predictors of lymph node metastasis in T1 colorectal carcinoma: an immunophenotypic analysis of 265 patients. Dis Colon Rectum. 2014;57(8):905\u201315.","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"363_CR20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10434-999-0433-5","volume":"6","author":"GD Steele Jr","year":"1999","unstructured":"Steele Jr GD et al. Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol. 1999;6(5):433\u201341.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"363_CR21","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s10350-008-9231-6","volume":"51","author":"JA Greenberg","year":"2008","unstructured":"Greenberg JA et al. Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984. Dis Colon Rectum. 2008;51(8):1185\u201391. discussion 1191\u20134.","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"363_CR22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00000658-200210000-00015","volume":"236","author":"PB Paty","year":"2002","unstructured":"Paty PB et al. Long-term results of local excision for rectal cancer. Ann Surg. 2002;236(4):522\u20139. discussion 529\u201330.","journal-title":"Ann Surg"},{"issue":"1","key":"363_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2007-1018451","volume":"17","author":"G Buess","year":"1985","unstructured":"Buess G et al. Endoscopic surgery in the rectum. Endoscopy. 1985;17(1):31\u20135.","journal-title":"Endoscopy"},{"issue":"1","key":"363_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9610(92)90254-O","volume":"163","author":"G Buess","year":"1992","unstructured":"Buess G et al. Technique and results of transanal endoscopic microsurgery in early rectal cancer. Am J Surg. 1992;163(1):63\u20139. discussion 69\u201370.","journal-title":"Am J Surg"},{"issue":"9","key":"363_CR25","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1007\/s00464-010-0927-z","volume":"24","author":"S Atallah","year":"2010","unstructured":"Atallah S, Albert M, Larach S. Transanal minimally invasive surgery: a giant leap forward. Surg Endosc. 2010;24(9):2200\u20135.","journal-title":"Surg Endosc"},{"issue":"1\u20132","key":"363_CR26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000091957","volume":"23","author":"S Maslekar","year":"2006","unstructured":"Maslekar S et al. Transanal endoscopic microsurgery: where are we now? Dig Surg. 2006;23(1\u20132):12\u201322.","journal-title":"Dig Surg"},{"issue":"11","key":"363_CR27","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/DCR.0b013e3181b14d2d","volume":"52","author":"ME Allaix","year":"2009","unstructured":"Allaix ME et al. Transanal endoscopic microsurgery for rectal neoplasms: experience of 300 consecutive cases. Dis Colon Rectum. 2009;52(11):1831\u20136.","journal-title":"Dis Colon Rectum"},{"issue":"33","key":"363_CR28","doi-asserted-by":"crossref","first-page":"11538","DOI":"10.3748\/wjg.v20.i33.11538","volume":"20","author":"X Serra-Aracil","year":"2014","unstructured":"Serra-Aracil X et al. Transanal endoscopic surgery in rectal cancer. World J Gastroenterol. 2014;20(33):11538\u201345.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"363_CR29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10151-014-1148-6","volume":"18","author":"B Martin-Perez","year":"2014","unstructured":"Martin-Perez B et al. A systematic review of transanal minimally invasive surgery (TAMIS) from 2010 to 2013. Tech Coloproctol. 2014;18(9):775\u201388. Review of literature for treatment of patients with early stage rectal cancer with TAMIS.","journal-title":"Tech Coloproctol"},{"issue":"3","key":"363_CR30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/DCR.0b013e31827ca313","volume":"56","author":"MR Albert","year":"2013","unstructured":"Albert MR et al. Transanal minimally invasive surgery (TAMIS) for local excision of benign neoplasms and early-stage rectal cancer: efficacy and outcomes in the first 50 patients. Dis Colon Rectum. 2013;56(3):301\u20137.","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"363_CR31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.amjsurg.2014.01.006","volume":"208","author":"EC McLemore","year":"2014","unstructured":"McLemore EC et al. Transanal minimally invasive surgery for benign and malignant rectal neoplasia. Am J Surg. 2014;208(3):372\u201381.","journal-title":"Am J Surg"},{"issue":"5","key":"363_CR32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10151-013-1095-7","volume":"18","author":"S Atallah","year":"2014","unstructured":"Atallah S et al. Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): results and experience with the first 20 patients undergoing curative-intent rectal cancer surgery at a single institution. Tech Coloproctol. 2014;18(5):473\u201380.","journal-title":"Tech Coloproctol"},{"issue":"8496","key":"363_CR33","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(86)91510-2","volume":"1","author":"RJ Heald","year":"1986","unstructured":"Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479\u201382.","journal-title":"Lancet"},{"issue":"8843","key":"363_CR34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0140-6736(93)90207-W","volume":"341","author":"JK MacFarlane","year":"1993","unstructured":"MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993;341(8843):457\u201360.","journal-title":"Lancet"},{"issue":"11","key":"363_CR35","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1245\/s10434-014-3762-y","volume":"21","author":"N Saito","year":"2014","unstructured":"Saito N et al. Long-term outcomes after intersphincteric resection for low-lying rectal cancer. Ann Surg Oncol. 2014;21(11):3608\u201315.","journal-title":"Ann Surg Oncol"},{"key":"363_CR36","doi-asserted-by":"crossref","unstructured":"Pachler J, Wille-J\u00f8rgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev. 2012;12:CD004323. doi: 10.1002\/14651858.CD004323.pub4 .","DOI":"10.1002\/14651858.CD004323.pub4"},{"issue":"3","key":"363_CR37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1470-2045(13)70016-0","volume":"14","author":"MH Pas van der","year":"2013","unstructured":"van der Pas MH et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14(3):210\u20138. Randomized phase 3 trial evaluating short term outcomes for laparoscopic versus open surgery in the treatment of rectal cancer. The study found similar short term outcomes between the 2 groups.","journal-title":"Lancet Oncol"},{"issue":"7","key":"363_CR38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1470-2045(10)70131-5","volume":"11","author":"SB Kang","year":"2010","unstructured":"Kang SB et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010;11(7):637\u201345.","journal-title":"Lancet Oncol"},{"issue":"1","key":"363_CR39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00464-012-2444-8","volume":"27","author":"J Lujan","year":"2013","unstructured":"Lujan J et al. Laparoscopic versus open surgery for rectal cancer: results of a prospective multicentre analysis of 4,970 patients. Surg Endosc. 2013;27(1):295\u2013302.","journal-title":"Surg Endosc"},{"issue":"11","key":"363_CR40","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/bjs.7160","volume":"97","author":"DG Jayne","year":"2010","unstructured":"Jayne DG et al. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg. 2010;97(11):1638\u201345.","journal-title":"Br J Surg"},{"issue":"7","key":"363_CR41","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1470-2045(14)70205-0","volume":"15","author":"SY Jeong","year":"2014","unstructured":"Jeong SY et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol. 2014;15(7):767\u201374.","journal-title":"Lancet Oncol"},{"key":"363_CR42","first-page":"Cd005200","volume":"4","author":"S Vennix","year":"2014","unstructured":"Vennix S et al. Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev. 2014;4:Cd005200.","journal-title":"Cochrane Database Syst Rev"},{"key":"363_CR43","doi-asserted-by":"crossref","unstructured":"Xiong B, et al. Robotic Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer: a Meta-analysis of Eight Studies. J Gastrointest Surg. 2014. Comprehensive review of patients with rectal cancer undergoing robotic or laparoscopic surgery showing no difference in short term outcomes between the two treatment modalities.","DOI":"10.1007\/s11605-014-2697-8"},{"issue":"5","key":"363_CR44","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3748\/wjg.v7.i5.612","volume":"7","author":"GB Makin","year":"2001","unstructured":"Makin GB, Breen DJ, Monson JR. The impact of new technology on surgery for colorectal cancer. World J Gastroenterol. 2001;7(5):612\u201321.","journal-title":"World J Gastroenterol"},{"key":"363_CR45","volume-title":"Shackelford's surgery of the alimentary tract","author":"CJ Yeo","year":"2013","unstructured":"Yeo CJ. Shackelford's surgery of the alimentary tract. 7th ed. Philadelphia: Elsevier Saunders; 2013.","edition":"7"},{"issue":"9","key":"363_CR46","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1046\/j.0007-1323.2001.01861.x","volume":"88","author":"S Manfredi","year":"2001","unstructured":"Manfredi S et al. Population-based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer. Br J Surg. 2001;88(9):1221\u20137.","journal-title":"Br J Surg"},{"issue":"10","key":"363_CR47","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00384-007-0306-y","volume":"22","author":"CF Platell","year":"2007","unstructured":"Platell CF. Changing patterns of recurrence after treatment for colorectal cancer. Int J Color Dis. 2007;22(10):1223\u201331.","journal-title":"Int J Color Dis"},{"issue":"7","key":"363_CR48","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s10350-004-0086-6","volume":"47","author":"TD Cecil","year":"2004","unstructured":"Cecil TD et al. Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum. 2004;47(7):1145\u20139. discussion 1149\u201350.","journal-title":"Dis Colon Rectum"},{"issue":"18","key":"363_CR49","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1200\/JCO.2001.19.18.3895","volume":"19","author":"L Stocchi","year":"2001","unstructured":"Stocchi L et al. Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol. 2001;19(18):3895\u2013902.","journal-title":"J Clin Oncol"},{"issue":"10","key":"363_CR50","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00268-002-6560-9","volume":"26","author":"WL Law","year":"2002","unstructured":"Law WL, Chu KW. Local recurrence following total mesorectal excision with double-stapling anastomosis for rectal cancers: analysis of risk factors. World J Surg. 2002;26(10):1272\u20136.","journal-title":"World J Surg"},{"issue":"3","key":"363_CR51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.coc.0000214930.78200.4a","volume":"29","author":"P Das","year":"2006","unstructured":"Das P et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol. 2006;29(3):219\u201324.","journal-title":"Am J Clin Oncol"},{"key":"363_CR52","first-page":"283","volume":"4","author":"GP Kanas","year":"2012","unstructured":"Kanas GP et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283\u2013301. Meta-analysis review demonstrating the survival benefit of liver resection inf the treatment of metastatic colon cancer.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"363_CR53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3816\/CCC.2003.n.010","volume":"3","author":"MO Meyers","year":"2003","unstructured":"Meyers MO, Sasson AR, Sigurdson ER. Locoregional strategies for colorectal hepatic metastases. Clin Colorectal Cancer. 2003;3(1):34\u201344.","journal-title":"Clin Colorectal Cancer"},{"issue":"11","key":"363_CR54","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/bjs.1800771115","volume":"77","author":"J Scheele","year":"1990","unstructured":"Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 1990;77(11):1241\u20136.","journal-title":"Br J Surg"},{"key":"363_CR55","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1200\/JCO.2010.32.8732","volume":"29","author":"RG Gray","year":"2011","unstructured":"Gray RG, Quirke P, Handley K, et al. Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction for assessment of recurrence risk in patients with stage II colon cancer. J Clin Oncol. 2011;29:4611\u20139.","journal-title":"J Clin Oncol"},{"issue":"14","key":"363_CR56","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1200\/JCO.2012.45.1096","volume":"31","author":"AP Venook","year":"2013","unstructured":"Venook AP, Niedzwiecki D, Lopatin M, et al. Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581. J Clin Oncol. 2013;31(14):1775\u201381.","journal-title":"J Clin Oncol"},{"key":"363_CR57","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andre","year":"2004","unstructured":"Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343\u201351.","journal-title":"N Engl J Med"},{"key":"363_CR58","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","volume":"27","author":"T Andre","year":"2009","unstructured":"Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27:3109\u201316.","journal-title":"J Clin Oncol"},{"key":"363_CR59","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1200\/JCO.2006.08.1075","volume":"25","author":"HJ Schmoll","year":"2007","unstructured":"Schmoll HJ, Cartwright T, Tabernero J, et al. Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients. J Clin Oncol. 2007;25:102\u20139.","journal-title":"J Clin Oncol"},{"issue":"22","key":"363_CR60","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.2011.749","volume":"305","author":"JJ Biagi","year":"2011","unstructured":"Biagi JJ, Raphael MJ, Mackillop WJ, et al. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA. 2011;305(22):2335\u201342.","journal-title":"JAMA"},{"key":"363_CR61","doi-asserted-by":"crossref","unstructured":"Ceelen WP, Van Nieuwenhove Y, Fierens K. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev. 2009:CD006041.","DOI":"10.1002\/14651858.CD006041.pub2"},{"issue":"1","key":"363_CR62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jnci\/dju345","volume":"107","author":"K Ng","year":"2014","unstructured":"Ng K, Meyerhardt J, Chan AT, et al. Aspirin and COX-2 inhibitor use in patients with stage III colon cancer. J Natl Cancer Inst. 2014;107(1):345.","journal-title":"J Natl Cancer Inst"},{"key":"363_CR63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11888-013-0181-6","volume":"9","author":"T Andre","year":"2013","unstructured":"Andre T, Iveson T, Labianca R, et al. The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective combined analysis of Phase III trials investigating duration of adjuvant therapy with the FOLFOX (FOLFOX4 or modified FOLFOX6) or XELOX (3 versus 6 months) regimen for patients with stage III colon cancer: Trial design and current status. Curr Color Cancer Rep. 2013;9:261\u20139.","journal-title":"Curr Color Cancer Rep"},{"issue":"15_suppl","key":"363_CR64","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1200\/jco.2010.28.15_suppl.3510","volume":"28","author":"J Garcia-Auilar","year":"2010","unstructured":"Garcia-Auilar J, Shi Q, Thomas CR, et al. Pathologic complete response (pCR) to neoadjuvant chemoradiation (CRT) of uT2N0 rectal cancer (RC) treated by local excision (LE): results of the ACOSOG Z6041 trial. J Clin Oncol. 2010;28(15_suppl):3510.","journal-title":"J Clin Oncol"},{"issue":"6875","key":"363_CR65","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/bmj.306.6875.419","volume":"306","author":"M Frisch","year":"1993","unstructured":"Frisch M, Melbye M, Moller H. Trends in incidence of anal cancer in Denmark. BMJ. 1993;306(6875):419\u201322.","journal-title":"BMJ"},{"issue":"2","key":"363_CR66","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","volume":"101","author":"LG Johnson","year":"2004","unstructured":"Johnson LG et al. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973\u20132000. Cancer. 2004;101(2):281\u20138.","journal-title":"Cancer"},{"key":"363_CR67","volume-title":"Current surgical therapy","author":"JL Cameron","year":"2014","unstructured":"Cameron JL, Cameron AM. Current surgical therapy. 11th ed. Philadelphia: Elsevier Saunders; 2014.","edition":"11"},{"issue":"5","key":"363_CR68","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1634\/theoncologist.12-5-524","volume":"12","author":"HE Uronis","year":"2007","unstructured":"Uronis HE, Bendell JC. Anal cancer: an overview. Oncologist. 2007;12(5):524\u201334.","journal-title":"Oncologist"},{"issue":"3","key":"363_CR69","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.radonc.2014.04.013","volume":"111","author":"R Glynne-Jones","year":"2014","unstructured":"Glynne-Jones R et al. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Radiother Oncol. 2014;111(3):330\u20139.","journal-title":"Radiother Oncol"},{"issue":"4","key":"363_CR70","doi-asserted-by":"crossref","first-page":"449","DOI":"10.6004\/jnccn.2012.0046","volume":"10","author":"AB Benson 3rd","year":"2012","unstructured":"Benson 3rd AB et al. Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw. 2012;10(4):449\u201354.","journal-title":"J Natl Compr Cancer Netw"},{"key":"363_CR71","doi-asserted-by":"crossref","first-page":"196068","DOI":"10.1155\/2014\/196068","volume":"2014","author":"C Caldarella","year":"2014","unstructured":"Caldarella C et al. Diagnostic performance of positron emission tomography\/computed tomography using fluorine-18 fluorodeoxyglucose in detecting locoregional nodal involvement in patients with anal canal cancer: a systematic review and meta-analysis. ScientificWorldJournal. 2014;2014:196068.","journal-title":"ScientificWorldJournal"},{"issue":"10","key":"363_CR72","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L","volume":"51","author":"ND Nigro","year":"1983","unstructured":"Nigro ND et al. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer. 1983;51(10):1826\u20139.","journal-title":"Cancer"},{"issue":"3","key":"363_CR73","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","volume":"17","author":"ND Nigro","year":"1974","unstructured":"Nigro ND, Vaitkevicius VK, Considine Jr B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 1974;17(3):354\u20136.","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"363_CR74","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink H et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15(5):2040\u20139.","journal-title":"J Clin Oncol"},{"issue":"9","key":"363_CR75","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","volume":"14","author":"M Flam","year":"1996","unstructured":"Flam M et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996;14(9):2527\u201339.","journal-title":"J Clin Oncol"},{"issue":"16","key":"363_CR76","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani JA et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA. 2008;299(16):1914\u201321.","journal-title":"JAMA"},{"issue":"6","key":"363_CR77","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James RD et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u2009\u00d7\u20092 factorial trial. Lancet Oncol. 2013;14(6):516\u201324.","journal-title":"Lancet Oncol"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-015-0363-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-015-0363-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-015-0363-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T13:44:51Z","timestamp":1652881491000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-015-0363-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,19]]},"references-count":77,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["363"],"URL":"https:\/\/doi.org\/10.1007\/s11864-015-0363-3","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,19]]},"article-number":"46"}}